GB9027767D0 - Binding substances - Google Patents

Binding substances

Info

Publication number
GB9027767D0
GB9027767D0 GB909027767A GB9027767A GB9027767D0 GB 9027767 D0 GB9027767 D0 GB 9027767D0 GB 909027767 A GB909027767 A GB 909027767A GB 9027767 A GB9027767 A GB 9027767A GB 9027767 D0 GB9027767 D0 GB 9027767D0
Authority
GB
United Kingdom
Prior art keywords
binding substances
substances
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909027767A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune Ltd
Original Assignee
Cambridge Antibody Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Antibody Technology Ltd filed Critical Cambridge Antibody Technology Ltd
Priority to GB909027767A priority Critical patent/GB9027767D0/en
Publication of GB9027767D0 publication Critical patent/GB9027767D0/en
Priority to JP4501749A priority patent/JPH06503956A/en
Priority to AU91071/91A priority patent/AU9107191A/en
Priority to EP92901859A priority patent/EP0563198A1/en
Priority to PCT/GB1991/002303 priority patent/WO1992011031A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
GB909027767A 1990-12-21 1990-12-21 Binding substances Pending GB9027767D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB909027767A GB9027767D0 (en) 1990-12-21 1990-12-21 Binding substances
JP4501749A JPH06503956A (en) 1990-12-21 1991-12-23 Targeting IgE effector cells to tumor cells
AU91071/91A AU9107191A (en) 1990-12-21 1991-12-23 Targetting ige effector cells to tumor cells
EP92901859A EP0563198A1 (en) 1990-12-21 1991-12-23 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS
PCT/GB1991/002303 WO1992011031A1 (en) 1990-12-21 1991-12-23 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027767A GB9027767D0 (en) 1990-12-21 1990-12-21 Binding substances

Publications (1)

Publication Number Publication Date
GB9027767D0 true GB9027767D0 (en) 1991-02-13

Family

ID=10687416

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909027767A Pending GB9027767D0 (en) 1990-12-21 1990-12-21 Binding substances

Country Status (5)

Country Link
EP (1) EP0563198A1 (en)
JP (1) JPH06503956A (en)
AU (1) AU9107191A (en)
GB (1) GB9027767D0 (en)
WO (1) WO1992011031A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE399022T1 (en) * 1995-10-20 2008-07-15 Univ Nebraska COMPOSITION AND METHOD FOR ENHANCING THE IMMUNE RESPONSE OF ANTIGEN-PRESENTING CELLS
AU5203199A (en) * 1998-05-26 1999-12-13 Procter & Gamble Company, The Chimeric molecules comprising an extracellular ligand binding domain of a receptor and an ige fc or constant region, and their use in an assay system
EP2331130B1 (en) * 2008-04-09 2018-02-14 Oncoquest Inc. Ige antibodies for the treatment of cancer
WO2009126819A1 (en) * 2008-04-09 2009-10-15 Advanced Immune Therapeutics, Inc. Methods for improving the bioactivity of therapeutic ige antibodies for the treatment of disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4676980A (en) * 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US4714759A (en) * 1985-12-02 1987-12-22 Whitaker Jr Robert B Immunotoxin therapy of allergy
US4902495A (en) * 1986-07-22 1990-02-20 The United States Of America As Represented By The Department Of Health And Human Services IgE Fc directed delivery system

Also Published As

Publication number Publication date
JPH06503956A (en) 1994-05-12
WO1992011031A1 (en) 1992-07-09
EP0563198A1 (en) 1993-10-06
AU9107191A (en) 1992-07-22

Similar Documents

Publication Publication Date Title
GB9105245D0 (en) Binding molecules
GB9016299D0 (en) Binding substances
GB9225453D0 (en) Binding proteins
GB2248044B (en) Improved doll-carriages
EP0550668A4 (en) Ibuprofen-antihistamine combinations
GB9027767D0 (en) Binding substances
ZA937445B (en) Binding element
GB2248607B (en) Improved fishbox
GB9005419D0 (en) Improved depanner
GB2242866B (en) Binder
GB9105074D0 (en) Improvements in binding
GB9210608D0 (en) Binding system
GB9024503D0 (en) Binding substances
ZA911688B (en) Binder
GB2249524B (en) Book binding
GB9110549D0 (en) Binding substances
GB9104744D0 (en) Binding substances
GB9120252D0 (en) Improvement binding substances
GB9212045D0 (en) Binding
GB9120377D0 (en) Improved binding substances
GB9206372D0 (en) Binding substances
GB9019552D0 (en) Specific binding agents
GB9009628D0 (en) Binding
AU109294S (en) Listello
ZW2791A1 (en) Binder